StockData
Agenus Inc logo

Agenus Inc (AGEN) stock

AGENNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 3/30
$6.29−0.44 (-6.54%)

Close on Nov 16, 2026Market cap $283.18MP/E –Yield –

Earnings

Agenus's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 15, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
$31.50M
EPS, Q3 FY2026
–
Latest guidance
Issued
May 12, 2025 · 1 item

Quarterly results

Revenue and earnings per share from each of Agenus's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Mar 15, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 5, 2026before the open$31.50M––Release
Q2 FY2026ended Jun 30, 2026Aug 6, 2026before the open$34.50M+34.2%–Release
Q1 FY2026ended Mar 31, 2026May 11, 2026before the open$33.70M+39.8%–Release
Q4 FY2025ended Dec 31, 2025Mar 16, 2026before the open–––Release
Q3 FY2025ended Sep 30, 2025Nov 10, 2025before the open–––Release
Q2 FY2025ended Jun 30, 2025Aug 11, 2025before the open$25.70M+9.4%–Release
Q1 FY2025ended Mar 31, 2025May 12, 2025before the open$24.10M-13.9%-$1.03Release
Q4 FY2024ended Dec 31, 2024Mar 11, 2025before the open$26.80M-68.1%-$2.04Release
Q3 FY2024ended Sep 30, 2024Nov 12, 2024before the open$25.10M+3.3%–Release
Q2 FY2024ended Jun 30, 2024Aug 8, 2024after the close$23.50M-7.1%-$2.52Release
Q1 FY2024ended Mar 31, 2024May 7, 2024before the open$28.00M+22.3%-$3.04Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

No open guidance: every period Agenus guided for has been reported

Guidance history

Every forecast Agenus put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
May 12, 2025annualized operating cash burnFY2025$50.00MNew

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Agenus filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. Update
  4. Update
  5. Results
  6. Results
  7. Update
  8. Update
  9. Results
  10. Results
  11. Update
  12. Results
  13. Results
  14. Update
  15. Results

See a number that looks wrong?